STUDY REGARDING ANTIBIORESISTANCE OF SALMONELLA STRAINS ISOLATED FROM FISH FLOUR
Abstract
Alimentary toxiinfections produced by Salmonella from view point of frequency and hygienic-sanitary implications are on the first place in most of countries. At animals the infection is maintained by recycling the waste from slaughterhouses as food for animals, fecal-oral transmission, and fecal contaminations of eggs. They are widely distributed in nature, with humans and animals being their primary reservoirs. All salmonellae have been placed in two species, S. enterica and S. bongori with 2,500 or so serovars being divided into 5 species or groups, most of which are classified under S. enterica, the type species. The major groups correspond to the following subspecies: group II (S. enterica subsp. salamae), group III a (S. enterica subsp. arizonae), group III b (S. enterica subsp. diarizonae); group IV (S. enterica subsp. houtenae); and group VI (S. enterica subsp. indica). The former group V organisms have been elevated to species status as S. bongori. Objective: Study regarding antibiorezistance of Salmonella strains isolated from fish flour. Design. From fish flour were isolated 9 Salmonella strains. Procedures. It's used the methodology ISO 6579/1997 respecting the identifications germs of genus Salmonella. It's was used selective mediums to represented agar BS (agar with sulfit de bismut), HE (agar Hektoen enteric) and XLD (agar with xiloza-lizina-dezoxicolat). The conformed biochemical and serological was been realized. The system of identification biochemical was API 20 E. Results. From fish flour were isolated 9 Salmonella strains (63%) as follows: Saint Paul (6%), Montevideo (6%), Newport (7%), London (6%), Choleraesuis (8%), Meleagridis (8%), Derby (12%), Dublin (4%), Agona (6%). It was tested the resistance of 9 strains isolated from fish flour against: streptomycin (S. montevideo), nalidixic acid (S. agona), tetracycline (S. newport, S. meleagridis, S. derby), flumequil si gentamicine (S. london) to observe multiresistant strains.a) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).